Recital 12, Regulation (EU) 2020/1043

In forcesince 15 Jul 2020

COVID-19 is a complex disease that affects multiple physiological processes. Potential treatments and vaccines are in development. Some of the vaccines in development contain attenuated viruses or live vectors, which may fall within the definition of a GMO.